Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors

Istvan J. Enyedy, Sukumar Sakamuri, Wahiduz A. Zaman, Kenneth M. Johnson, Shaomeng Wang

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Abnormal dopamine signaling in brain has been implicated in several conditions such as cocaine abuse, Parkinson's disease and depression. Potent and selective dopamine transporter inhibitors may be useful as pharmacological tools and therapeutic agents. Simple substituted pyridines were discovered as novel dopamine transporter (DAT) inhibitors through pharmacophore-based 3D-database search. The most potent compound 18 has a Ki value of 79 nM in inhibition of WIN35,248 binding to dopamine transporter and 255 nM in inhibition of dopamine reuptake, respectively, as potent as cocaine. Preliminary structure-activity relationship studies show that the geometry and the nature of the substituents on the pyridine ring determine the inhibitory activity and selectivity toward the three monoamine transporters. The substituted pyridines described herein represent a class of novel DAT inhibitors with simple chemical structures and their discovery provides additional insights into the binding site of DAT.

Original languageEnglish (US)
Pages (from-to)513-517
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume13
Issue number3
DOIs
StatePublished - Feb 2003

Fingerprint

Pyridines
Dopamine Plasma Membrane Transport Proteins
Cocaine
Dopamine
Cocaine-Related Disorders
Structure-Activity Relationship
Parkinson Disease
Brain
Binding Sites
Databases
Pharmacology
Depression
Geometry

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors. / Enyedy, Istvan J.; Sakamuri, Sukumar; Zaman, Wahiduz A.; Johnson, Kenneth M.; Wang, Shaomeng.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 13, No. 3, 02.2003, p. 513-517.

Research output: Contribution to journalArticle

Enyedy, Istvan J. ; Sakamuri, Sukumar ; Zaman, Wahiduz A. ; Johnson, Kenneth M. ; Wang, Shaomeng. / Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors. In: Bioorganic and Medicinal Chemistry Letters. 2003 ; Vol. 13, No. 3. pp. 513-517.
@article{fa354ec354b04a4785072e64739fe6e2,
title = "Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors",
abstract = "Abnormal dopamine signaling in brain has been implicated in several conditions such as cocaine abuse, Parkinson's disease and depression. Potent and selective dopamine transporter inhibitors may be useful as pharmacological tools and therapeutic agents. Simple substituted pyridines were discovered as novel dopamine transporter (DAT) inhibitors through pharmacophore-based 3D-database search. The most potent compound 18 has a Ki value of 79 nM in inhibition of WIN35,248 binding to dopamine transporter and 255 nM in inhibition of dopamine reuptake, respectively, as potent as cocaine. Preliminary structure-activity relationship studies show that the geometry and the nature of the substituents on the pyridine ring determine the inhibitory activity and selectivity toward the three monoamine transporters. The substituted pyridines described herein represent a class of novel DAT inhibitors with simple chemical structures and their discovery provides additional insights into the binding site of DAT.",
author = "Enyedy, {Istvan J.} and Sukumar Sakamuri and Zaman, {Wahiduz A.} and Johnson, {Kenneth M.} and Shaomeng Wang",
year = "2003",
month = "2",
doi = "10.1016/S0960-894X(02)00943-5",
language = "English (US)",
volume = "13",
pages = "513--517",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors

AU - Enyedy, Istvan J.

AU - Sakamuri, Sukumar

AU - Zaman, Wahiduz A.

AU - Johnson, Kenneth M.

AU - Wang, Shaomeng

PY - 2003/2

Y1 - 2003/2

N2 - Abnormal dopamine signaling in brain has been implicated in several conditions such as cocaine abuse, Parkinson's disease and depression. Potent and selective dopamine transporter inhibitors may be useful as pharmacological tools and therapeutic agents. Simple substituted pyridines were discovered as novel dopamine transporter (DAT) inhibitors through pharmacophore-based 3D-database search. The most potent compound 18 has a Ki value of 79 nM in inhibition of WIN35,248 binding to dopamine transporter and 255 nM in inhibition of dopamine reuptake, respectively, as potent as cocaine. Preliminary structure-activity relationship studies show that the geometry and the nature of the substituents on the pyridine ring determine the inhibitory activity and selectivity toward the three monoamine transporters. The substituted pyridines described herein represent a class of novel DAT inhibitors with simple chemical structures and their discovery provides additional insights into the binding site of DAT.

AB - Abnormal dopamine signaling in brain has been implicated in several conditions such as cocaine abuse, Parkinson's disease and depression. Potent and selective dopamine transporter inhibitors may be useful as pharmacological tools and therapeutic agents. Simple substituted pyridines were discovered as novel dopamine transporter (DAT) inhibitors through pharmacophore-based 3D-database search. The most potent compound 18 has a Ki value of 79 nM in inhibition of WIN35,248 binding to dopamine transporter and 255 nM in inhibition of dopamine reuptake, respectively, as potent as cocaine. Preliminary structure-activity relationship studies show that the geometry and the nature of the substituents on the pyridine ring determine the inhibitory activity and selectivity toward the three monoamine transporters. The substituted pyridines described herein represent a class of novel DAT inhibitors with simple chemical structures and their discovery provides additional insights into the binding site of DAT.

UR - http://www.scopus.com/inward/record.url?scp=0037328212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037328212&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(02)00943-5

DO - 10.1016/S0960-894X(02)00943-5

M3 - Article

VL - 13

SP - 513

EP - 517

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 3

ER -